Completed PHASE1 INTERVENTIONAL 6-arm NCT03011996

To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration

An Open-label, Randomized Study to Evaluate Pharmacokinetic Interaction, Pharmacodynamics and Safety After Multiple Oral Dosing of CJ-12420 and Amoxicillin/Clarithromycin in Healthy Subjects

Sponsor: HK inno.N Corporation

Conditions Drug Interaction Pharmacodynamic Pharmacokinetic

Interventions AMX 1g CJ-12420 100mg CJ-12420 50mg CLR 500mg Pantoprazole 40mg

Updated 8 times since 2017 Last updated: May 11, 2017 Started: May 31, 2016 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03011996, this PHASE1 trial focuses on Drug Interaction and Pharmacodynamic and remains completed. Sponsored by HK inno.N Corporation, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Aug 2020 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2018 — Aug 2020 [monthly]

Completed PHASE1
Jun 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE1

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HK inno.N Corporation

Data source: HK inno.N Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Busan, South Korea